SlideShare a Scribd company logo
Manufacturer Evidence and applications for
inclusion in the ARTG
Medical Devices
Susan Barker
Devices Application and Verification Section
Medical Devices Branch
Devices Sponsor Information Day
11 October 2017
Purpose
Facilitate better understanding of the regulatory
requirements for medical devices
ARTG inclusion – explain the process and give
some examples
2
Overview
• Key definitions and regulatory framework
• Manufacturer’s Evidence
• Information in an application
• Avoiding common problems in applications
3
What is a medical device?
• Used for human beings
• Intended purpose
– Diagnosis, prevention, monitoring, treatment or alleviation of disease or compensation for injury
or disability
– Investigation, replacement or modification of anatomy or physiological processes
– Control of conception
• Principal intended action
– Not by pharmacological, immunological or metabolic means
• Definition of IVD in the MD Regulations
• Products declared to be or not to be a medical device
– Therapeutic Goods (Articles that are Medical Devices) Specification and/or
Therapeutic Goods (Articles that are not Medical Devices) Orders
• Accessory to a medical device as described above
Therapeutic Goods Act 1989, section 41BD 4
What is an IVD?
• A reagent, calibrator, control material, kit, specimen receptacle, instrument,
software, equipment or system
• Intended for the in vitro examination of human specimens for
– giving information about a physiological or pathological state
– giving information about a congenital abnormality
– determining safety and compatibility with a potential recipient
– monitoring therapeutic measures
Therapeutic Goods (Medical Devices) Regulations 2002, Dictionary
5
ARTG inclusion
• Any medical device must be included in ARTG
• Except:
- Exempt devices (e.g. custom-made medical devices)
• Sponsor is responsible for ARTG inclusion
• Before you start
• TGA Business Services (TBS)
– Register and get your Client ID
6
Process for ARTG inclusion
Basics - process through TGA
7
Manufacturer evidence
• Manufacturer must apply appropriate conformity assessment procedure to the device
(quality management system and control over the design of the device)
• Sponsor must lodge the manufacturer’s certification of the conformity assessment with the
TGA
- Except for Class I medical devices (no measuring function and/or not supplied sterile),
Class 1 IVD, and/or Export Only
• TGA conformity assessment certificate
• EC Certificate issued under MDD 93/42/EEC, AIMDD 90/385/EEC, IVD 98/79/EC
• MRA certificates issued by EU Notified Body (with certain exceptions)
• Declarations of conformity made under Clause 7.5 of Schedule 3 (systems or procedure
packs)
• ISO 13485 for IVDs only 8
Manufacturer Evidence
Submitted
Accepted
−What does it mean?
Go to the next step - lodging application
for ARTG inclusion
9
Application for ARTG inclusion
• Must be made for a kind of device and
• Must be made in accordance with a form and manner approved (via
TBS) and
• Application fee must be paid and
• For the devices that must have TGA conformity assessment certificate
– such certificate is in force and
• Must not contain information that is false or misleading in a material
particular
Therapeutic Goods Act 1989, sections 41FC and 41EA, and Therapeutic Goods (Medical Devices) Regulations 2002, regulation 4.1
10
What we look at
Kind of device
Intended Purpose
GMDN Code
Device Product Characteristics
Classification
Conformity Assessment Procedures
11
Kind of device
• Sponsor
• Manufacturer
• Device nomenclature system code (GMDN)
• Classification
• Unique product identifier (UPI)
(for Class III and active implantable medical devices (AIMD), and
Class 4IVD, except immunohaematology reagent)
a medical device is taken to
be of the same kind as
another medical device if
they have the same:
Therapeutic Goods Act 1989, section 41BE and Therapeutic Goods (Medical
Devices) Regulations 2002, regulations 1.6 and 1.7 12
Intended purpose of a kind of device
• Means the purpose for which the manufacturer of the device intends
it to be used, as stated in the information provided with the device
(labelling, instructions for use, advertising material and technical
documentation)
• Intended purpose stated in the application must be consistent with
the purpose for which the manufacturer intends the devices of the kind
to be used
Note: The manufacturer must have evidence that the device
performs as intended (refer essential principles)
13
Global Medical Device Nomenclature (GMDN)
- One of the characteristics that defines the kind of device
- Is to be consistent with the intended purpose of the device
- Must be the code that best describes the kind of device
- For medical devices (not-IVD) – relevant preferred term (except Class
I – relevant template term)
- For IVDs - collective terms (Level 1, 2 or 3) (except
Class 4IVD that is not immunohaematology reagent - relevant
preferred term)
Manufacturer’s responsibility 14
Device Product Characteristics
• Ensure ‘Device Product Characteristics’ section in the application is
correctly filled in
15
Medical devices are classified having regard to
the intended purpose of the device
Class I Class Is and
Class Im
Class IIa Class IIb Class III and
AIMD
The lowest level The highest level
Therapeutic Goods (Medical Devices) Regulations 2002, Part 3
Division 3.1 and Schedules 2 16
IVD medical devices are classified having regard to the
intended purpose of the device and its risk to public health
and/or personal risk
• Class 1 IVD – no public health risk or low personal risk
• Class 2 IVD – low public health risk or moderate personal risk
• Class 3 IVD – moderate public health risk or high personal risk
• Class 4 IVD – high public health risk
RISK
Therapeutic Goods (Medical Devices) Regulations 2002, Schedules 2A
17
Conformity assessment procedure
• Minimum conformity assessment procedures for different Classes
of devices
• Sufficient information to demonstrate application of the appropriate
conformity assessment procedures to the kind of device
Part 3 Division 3.2 and Schedule 3, Therapeutic Goods (Medical Devices) Regulations 2002
18
Conformity assessment procedures
• Minimum conformity assessment procedures for different Classes of
devices
Class Is device
(e.g. Sterile surgical gown)
Class III device
supplied sterile
(e.g. Knee Femur)
Annex II.3 - Full Quality Assurance
Annex V – Production Quality
Plus
Declaration of conformity
(Part 6, Schedule 3)
Annex III - Type Examination
Plus:
Annex V - Production Quality Assurance
Annex II.3 - Full Quality Assurance
Plus
Annex II.4 - Examination of Design
OR
OR
19
One page document
• Describe the device and intended purpose if needed in more detail
• Cite the classification rules in accordance with
Schedule 2 or 2A of the Regulations and provide justification where
required
• Explain how the kind of device is covered under the scope of certificate
included in Manufacturer’s Evidence
• Make sure all the information is complete and correct
• Do not attach more than one page
20
Information provided in the application
• Do not attach information that is not relevant with the
application, for example:
– Declaration of conformity made under EU Medical Device
Directive
– Audit and/or technical data reports
• Ensure intended purpose is clear and correct
• Ensure the device is classified correctly
• Ensure the Manufacturer’s Evidence stated in the application
contains correct certificate
21
Examples of common mistakes
Incorrect Device
Product Characteristics
GMDN code not most
relevant for the kind of
device
Incorrect Classification
Scope of EC certificate
does not correctly cover
the kind of device
Attaching documents not
relevant, which do not
meet requirements
22
Where do we go from here?
Matters certified under s.41FD
Ensure all information provided is correct
Any application may be selected for audit
Some applications must be selected for audit
23
SME Assist
• Guidance on TGA website
• Interactive online tool
24
Further information
• Medical devices (http://www.tga.gov.au/medical-devices-ivds)
• SME Assist (https://www.tga.gov.au/sme-assist)
TGA website
• Therapeutic Goods Act 1989 Chapter 3, Part 4-5
• Therapeutic Goods (Medical Devices) Regulations 2002
Federal Register of Legislation
• devices@tga.gov.au ph.: 1800 141 144
Contact the TGA Medical Devices Branch
25
Thank you!
26
Juliana William
Sr RA Associate
Baxter Healthcare
11/10/2017 Devices Sponsor Information Day 28
Agenda
Successful and Efficient Submission
 Preparation
 Checks to do
 Additional information
 Non-mandatory audit submissions
This presentation will not cover details of:
• Systems and Procedure Packs
• Conformity Assessment
• Audit Assessment
• Class III/AIMD, UPI and Variants
• Clinical Evidence & Risk Assessment compliance
11/10/2017 Devices Sponsor Information Day 29
Common Deficiencies
Manufacturer Evidence
(ME)
• Two or more
certificates are
provided
• EU declaration of
Conformity
• ISO 13485 certificate
• Incomplete certificate
(missing attachments)
• Incorrect annex route
• Incorrect directive
• Not in English!
Device Application
(DA)
• GMDN code does no
match the ‘Intended
purpose’
• Wrong classification
• Device is not covered in
the EC Certificate scope
• Route of conformity (EC
Certificate Annex) is not
appropriate for the
proposed Class
• Wrong manufacturer
evidence!
Administrative
• Missing documents or
pages!
• TGA evaluator unable to
find information easily
• Poor hyperlinking and
bookmarking
• Spelling errors
• Poor English Translation
• Missing signatures!
• Application fees not
processed
11/10/2017 Devices Sponsor Information Day 30
Preparation
 Ensure a legal/quality/distribution agreement is/are in place which outline
clearly roles and responsibilities for post-market monitoring, vigilance and
reporting obligations
 Obtain Australian Declaration of Conformity from manufacturer
 Make sure you have the right template for class and conformity route. See
http://www.tga.gov.au/industry/devices-forms-declaration-conformity.htm
 Ensure the codes listed are the code to be registered and marketed
 Obtain Australian Essential Principles Checklist from manufacturer
● Ensure compliance with all standards applied and compliance with the Australian EP. Section 8 of the ARGMD
explain the differences between EU ER and Australia EP.
 Product Labelling and Instruction for Use
 Risk Management Report and Clinical Evaluation Report
11/10/2017 Devices Sponsor Information Day 31
Checks to Do
 Check whether the device:
 Sterile? What is the sterilisation method
 Measuring function?
 Invasive?
 Reusable or Single Use?
 Active?
 Single product or System or Procedure pack?
 Contains a medicine?
 Contains material or ingredients of microbial/ recombinant / GMO/ animal/ human
origin? Country of origin?
 Is the device classified correctly according to the TGA Classification
Rules? (Schedule 2 of The Regulations)
11/10/2017 Devices Sponsor Information Day 32
Checks to Do
The medical devices regulatory
framework has a classification system
for medical devices.
The detailed legislation is in:
• 41BD of the Therapeutic Goods Act
1989 (the Act)
• Regulation 3.2 of the Therapeutic
Goods (Medical Devices)
Regulations 2002 (the Regulations)
• Schedule 2 of the Regulations.
11/10/2017 Devices Sponsor Information Day 33
Checks to Do
• Is the assigned GMDN code appropriate? (Section 10 of the Regulation)
 Remember that manufacturer assign the GMDN code.
 Check if the GMDN is on the TGA database. If the GMDN code is not in the TGA database,
ask for it to be added in advance by email to ebs@tga.gov.au
 There may be differences between the GMDN Agency code table database and the TGA code
table database.
 Based on the Device information, is the GMDN appropriate and reflects the intended
purpose?
 Must be a preferred term
 Does the device perform according to its intended purpose?
 This should be a detailed description of the manufacturers intended purpose and should closely
align with the relevant GMDN description
 Remember: Intended purpose is different from Functional description (describes the
operation of the medical device, not its composition)
11/10/2017 Devices Sponsor Information Day 34
Checks to Do
● Is the device same kind of medical device (Section 41BE of The Act)?
A medical device is of the same ‘kind’ if it has the same:
 Intended purpose
 Classification
 GMDN code
 Legal manufacturer
 Sponsor
 Does it have appropriate evidence of Conformity Assessment?
 ARGMD Section 5 Conformity Assessment Overview
 Need to check the appropriate level and route is held by the manufacturer
according to the classification
11/10/2017 Devices Sponsor Information Day 35
Checks to Do
11/10/2017 Devices Sponsor Information Day 36
Checks to Do
There are a number of
important details that a
sponsor should check to
ensure that the certificate
is valid for particular
devices.
Refer to Section 7 of the
ARGMD
11/10/2017 Devices Sponsor Information Day 37
Additional Information
If there is additional information that could help the assessor, then it would
be beneficial to attach a ONE PAGE ONLY document with the application
illustrating:
 A Picture/diagram of the device
 A description of the device (not the intended purpose)
 A description of the mechanism of action (how it works)
 How the device is included in the scope of the CE Certificate
 Evidence of the same kind of medical device (for multiple devices)
11/10/2017 Devices Sponsor Information Day 38
Non-mandatory audit
 Any Device Application is subject to non-mandatory audit.
 Be prepared to submit any documents from Level 1 or 2 audit list, as well as anything else you may
need to show compliance with any of the Essential Principles or Conformity Assessment
Procedures.
Examples:
 Compliance with Essential Principles
 Notified Body audit reports to verify the validity of the EC Certificate
 Product labelling and IFU
 Explanation and justification of Classification
 Recent Clinical Evaluation Report
 Recent Risk Management File
 Compliance with particular standards (or justification why it is not complied with)
 Remember you declare you can submit in 20 days!
11/10/2017 Devices Sponsor Information Day 39
Non-mandatory audit
 Provides all items requested by the TGA
 Electronic and easy to navigate (entire document):
 Clear table of content (hyperlinking and bookmarking work!)
 Text readable
 Page numbers throughout
 Up-to-date Clinical Evidence Report (signed by a clinical expert!)
 Up-to-date Risk Management File
 Well prepared submission will:
 Allow the delegate to easily navigate and find information quickly.
 Reduce the number of questions raised by the delegate
 Speed approval
The better quality the submission, the easier it is to read and evaluate
11/10/2017 Devices Sponsor Information Day 40
Wrap Up
 Make sure you understand your product.
 Do your preparation and verify information before submission! Time spent before submitting
is well worth it and will increase your success rate
 Engage your cross function team (R&D/Quality/Medical/Clinical..etc) well in advance of your
submission plan. Discuss application requirements and TGA’s expectation.
 Submit meaningful, helpful and well-set out information. Perform second check before sending
application and electronic files
 Clearly explain the scope of your application in the cover letter
 Provide comprehensive Table of Content
 Ensure all hyperlinks and bookmarks are actually working
 Ensure all documents and attachments are provided with the application!
 Don’t submit extra documents that aren’t useful or haven’t been requested
11/10/2017 Devices Sponsor Information Day 41
References
The Act
Therapeutic Goods Act 1989
The Regulations
Therapeutic Goods (Medical Device) Regulations 2002
ARGMD
Australian Regulatory Guidance for Medical Devices
11/10/2017 Devices Sponsor Information Day 42
Questions?
11/10/2017 Devices Sponsor Information Day 43

More Related Content

What's hot

Brazil medical device registration and approval chart - EMERGO
Brazil medical device registration and approval chart - EMERGOBrazil medical device registration and approval chart - EMERGO
Brazil medical device registration and approval chart - EMERGO
EMERGO
 
The European Medical Device Regulations - analysis of the final text
The European Medical Device Regulations - analysis of the final textThe European Medical Device Regulations - analysis of the final text
The European Medical Device Regulations - analysis of the final text
pi
 
MDD 93/42/EEC
MDD 93/42/EECMDD 93/42/EEC
MDD 93/42/EEC
Pavan Kumar Malwade
 
Medical Devices Regulation (MDR) 2017/745 - Part I Purpose, Scope, Definitions
Medical Devices Regulation (MDR)  2017/745 - Part I Purpose, Scope, DefinitionsMedical Devices Regulation (MDR)  2017/745 - Part I Purpose, Scope, Definitions
Medical Devices Regulation (MDR) 2017/745 - Part I Purpose, Scope, Definitions
Arete-Zoe, LLC
 
FDA Unique Device Identification (UDI) Overview
FDA Unique Device Identification (UDI) OverviewFDA Unique Device Identification (UDI) Overview
FDA Unique Device Identification (UDI) Overview
Caroline Bloemker, M.S., RAC
 
Medical Devices Product Lifecycle
Medical Devices Product LifecycleMedical Devices Product Lifecycle
Medical Devices Product Lifecycle
SanthiNori1
 
ISO Standard 13485
ISO Standard 13485ISO Standard 13485
ISO Standard 13485
Himanshi Arora
 
Premarket Notification 510(k) for Biologics [Autosaved].pptx
Premarket Notification 510(k) for Biologics [Autosaved].pptxPremarket Notification 510(k) for Biologics [Autosaved].pptx
Premarket Notification 510(k) for Biologics [Autosaved].pptx
SusmithaTella2
 
Canada medical device approval chart - EMERGO
Canada medical device approval chart - EMERGOCanada medical device approval chart - EMERGO
Canada medical device approval chart - EMERGO
EMERGO
 
PMS and PMCF report
PMS and PMCF reportPMS and PMCF report
PMS and PMCF report
Sakthisri87
 
Quality System Requirements 21 CFR Part 820 and Labelling Requirements for Me...
Quality System Requirements 21 CFR Part 820 and Labelling Requirements for Me...Quality System Requirements 21 CFR Part 820 and Labelling Requirements for Me...
Quality System Requirements 21 CFR Part 820 and Labelling Requirements for Me...
Swapnil Fernandes
 
The regulation of IVD medical devices
The regulation of IVD medical devicesThe regulation of IVD medical devices
The regulation of IVD medical devices
TGA Australia
 
Regulation of Medical Devices in US
Regulation of Medical Devices in USRegulation of Medical Devices in US
Regulation of Medical Devices in US
Ankit Geete
 
GHTF study group 3
GHTF study group 3GHTF study group 3
GHTF study group 3
Nirma University
 
UDI
UDIUDI
ASEAN COUNTRIES.pptx
ASEAN COUNTRIES.pptxASEAN COUNTRIES.pptx
ASEAN COUNTRIES.pptx
AartiVats5
 
The regulation of medical devices in Australia
The regulation of medical devices in AustraliaThe regulation of medical devices in Australia
The regulation of medical devices in Australia
TGA Australia
 
Europe IVD medical registration and approval chart - EMERGO
Europe IVD medical registration and approval chart - EMERGOEurope IVD medical registration and approval chart - EMERGO
Europe IVD medical registration and approval chart - EMERGO
EMERGO
 
ISO 14155.pdf
ISO 14155.pdfISO 14155.pdf
ISO 14155.pdf
Zeelshah2258
 
ISO 13485: Quality Management System for Medical Device
ISO 13485: Quality Management System for Medical DeviceISO 13485: Quality Management System for Medical Device
ISO 13485: Quality Management System for Medical Device
MananShah147368
 

What's hot (20)

Brazil medical device registration and approval chart - EMERGO
Brazil medical device registration and approval chart - EMERGOBrazil medical device registration and approval chart - EMERGO
Brazil medical device registration and approval chart - EMERGO
 
The European Medical Device Regulations - analysis of the final text
The European Medical Device Regulations - analysis of the final textThe European Medical Device Regulations - analysis of the final text
The European Medical Device Regulations - analysis of the final text
 
MDD 93/42/EEC
MDD 93/42/EECMDD 93/42/EEC
MDD 93/42/EEC
 
Medical Devices Regulation (MDR) 2017/745 - Part I Purpose, Scope, Definitions
Medical Devices Regulation (MDR)  2017/745 - Part I Purpose, Scope, DefinitionsMedical Devices Regulation (MDR)  2017/745 - Part I Purpose, Scope, Definitions
Medical Devices Regulation (MDR) 2017/745 - Part I Purpose, Scope, Definitions
 
FDA Unique Device Identification (UDI) Overview
FDA Unique Device Identification (UDI) OverviewFDA Unique Device Identification (UDI) Overview
FDA Unique Device Identification (UDI) Overview
 
Medical Devices Product Lifecycle
Medical Devices Product LifecycleMedical Devices Product Lifecycle
Medical Devices Product Lifecycle
 
ISO Standard 13485
ISO Standard 13485ISO Standard 13485
ISO Standard 13485
 
Premarket Notification 510(k) for Biologics [Autosaved].pptx
Premarket Notification 510(k) for Biologics [Autosaved].pptxPremarket Notification 510(k) for Biologics [Autosaved].pptx
Premarket Notification 510(k) for Biologics [Autosaved].pptx
 
Canada medical device approval chart - EMERGO
Canada medical device approval chart - EMERGOCanada medical device approval chart - EMERGO
Canada medical device approval chart - EMERGO
 
PMS and PMCF report
PMS and PMCF reportPMS and PMCF report
PMS and PMCF report
 
Quality System Requirements 21 CFR Part 820 and Labelling Requirements for Me...
Quality System Requirements 21 CFR Part 820 and Labelling Requirements for Me...Quality System Requirements 21 CFR Part 820 and Labelling Requirements for Me...
Quality System Requirements 21 CFR Part 820 and Labelling Requirements for Me...
 
The regulation of IVD medical devices
The regulation of IVD medical devicesThe regulation of IVD medical devices
The regulation of IVD medical devices
 
Regulation of Medical Devices in US
Regulation of Medical Devices in USRegulation of Medical Devices in US
Regulation of Medical Devices in US
 
GHTF study group 3
GHTF study group 3GHTF study group 3
GHTF study group 3
 
UDI
UDIUDI
UDI
 
ASEAN COUNTRIES.pptx
ASEAN COUNTRIES.pptxASEAN COUNTRIES.pptx
ASEAN COUNTRIES.pptx
 
The regulation of medical devices in Australia
The regulation of medical devices in AustraliaThe regulation of medical devices in Australia
The regulation of medical devices in Australia
 
Europe IVD medical registration and approval chart - EMERGO
Europe IVD medical registration and approval chart - EMERGOEurope IVD medical registration and approval chart - EMERGO
Europe IVD medical registration and approval chart - EMERGO
 
ISO 14155.pdf
ISO 14155.pdfISO 14155.pdf
ISO 14155.pdf
 
ISO 13485: Quality Management System for Medical Device
ISO 13485: Quality Management System for Medical DeviceISO 13485: Quality Management System for Medical Device
ISO 13485: Quality Management System for Medical Device
 

Viewers also liked

Presentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence GuidelinesPresentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence Guidelines
TGA Australia
 
TGA presentation: medical devices audit assessments
TGA presentation: medical devices audit assessmentsTGA presentation: medical devices audit assessments
TGA presentation: medical devices audit assessments
TGA Australia
 
Presentation: Conformity Assessment Evidence
Presentation: Conformity Assessment EvidencePresentation: Conformity Assessment Evidence
Presentation: Conformity Assessment Evidence
TGA Australia
 
TGA presentation: Lifecycle of a Medical Device / IVD
TGA presentation: Lifecycle of a Medical Device / IVDTGA presentation: Lifecycle of a Medical Device / IVD
TGA presentation: Lifecycle of a Medical Device / IVD
TGA Australia
 
TGA presentation: The role of the TGA
TGA presentation: The role of the TGATGA presentation: The role of the TGA
TGA presentation: The role of the TGA
TGA Australia
 
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
TGA Australia
 
Harry Surden - Artificial Intelligence and Law Overview
Harry Surden - Artificial Intelligence and Law OverviewHarry Surden - Artificial Intelligence and Law Overview
Harry Surden - Artificial Intelligence and Law Overview
Harry Surden
 
Inside Google's Numbers in 2017
Inside Google's Numbers in 2017Inside Google's Numbers in 2017
Inside Google's Numbers in 2017
Rand Fishkin
 

Viewers also liked (8)

Presentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence GuidelinesPresentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence Guidelines
 
TGA presentation: medical devices audit assessments
TGA presentation: medical devices audit assessmentsTGA presentation: medical devices audit assessments
TGA presentation: medical devices audit assessments
 
Presentation: Conformity Assessment Evidence
Presentation: Conformity Assessment EvidencePresentation: Conformity Assessment Evidence
Presentation: Conformity Assessment Evidence
 
TGA presentation: Lifecycle of a Medical Device / IVD
TGA presentation: Lifecycle of a Medical Device / IVDTGA presentation: Lifecycle of a Medical Device / IVD
TGA presentation: Lifecycle of a Medical Device / IVD
 
TGA presentation: The role of the TGA
TGA presentation: The role of the TGATGA presentation: The role of the TGA
TGA presentation: The role of the TGA
 
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
 
Harry Surden - Artificial Intelligence and Law Overview
Harry Surden - Artificial Intelligence and Law OverviewHarry Surden - Artificial Intelligence and Law Overview
Harry Surden - Artificial Intelligence and Law Overview
 
Inside Google's Numbers in 2017
Inside Google's Numbers in 2017Inside Google's Numbers in 2017
Inside Google's Numbers in 2017
 

Similar to TGA Presentation: Medical Devices - Manufacturer Evidence and applications for inclusion in the ARTG

Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...
Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...
Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...
TGA Australia
 
Devices Sponsor Information Day - Medical Devices (IVDs) - Applications for A...
Devices Sponsor Information Day - Medical Devices (IVDs) - Applications for A...Devices Sponsor Information Day - Medical Devices (IVDs) - Applications for A...
Devices Sponsor Information Day - Medical Devices (IVDs) - Applications for A...
TGA Australia
 
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
TGA Australia
 
Devices Sponsor Information Day: Session 3B: Medical devices (IVDs) - applica...
Devices Sponsor Information Day: Session 3B: Medical devices (IVDs) - applica...Devices Sponsor Information Day: Session 3B: Medical devices (IVDs) - applica...
Devices Sponsor Information Day: Session 3B: Medical devices (IVDs) - applica...
TGA Australia
 
Devices Sponsor Information Day: 4A - Medical Devices - Audit assessments
Devices Sponsor Information Day: 4A - Medical Devices - Audit assessmentsDevices Sponsor Information Day: 4A - Medical Devices - Audit assessments
Devices Sponsor Information Day: 4A - Medical Devices - Audit assessments
TGA Australia
 
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...
TGA Australia
 
The challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesThe challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devices
TGA Australia
 
Presentation: Update from the Medical Devices Branch
Presentation: Update from the Medical Devices BranchPresentation: Update from the Medical Devices Branch
Presentation: Update from the Medical Devices Branch
TGA Australia
 
Sponsor Information and Training day Session C1 - IVDs: eBS applications and ...
Sponsor Information and Training day Session C1 - IVDs: eBS applications and ...Sponsor Information and Training day Session C1 - IVDs: eBS applications and ...
Sponsor Information and Training day Session C1 - IVDs: eBS applications and ...
TGA Australia
 
Future of EU In Vitro Diagnostics Regulation
Future of EU In Vitro Diagnostics RegulationFuture of EU In Vitro Diagnostics Regulation
Future of EU In Vitro Diagnostics Regulation
Erik Vollebregt
 
EU MDD.pptx
EU MDD.pptxEU MDD.pptx
EU MDD.pptx
AartiVats5
 
Devices Sponsor Information Day: 0 - Developments in medical device regulation
Devices Sponsor Information Day: 0 - Developments in medical device regulationDevices Sponsor Information Day: 0 - Developments in medical device regulation
Devices Sponsor Information Day: 0 - Developments in medical device regulation
TGA Australia
 
Medical Device Regulatory Approval
Medical Device Regulatory ApprovalMedical Device Regulatory Approval
Medical Device Regulatory Approvalruyang89
 
Lancashire SME workshop - regulation and medical device workshop
Lancashire SME workshop - regulation and medical device workshopLancashire SME workshop - regulation and medical device workshop
Lancashire SME workshop - regulation and medical device workshop
Innovation Agency
 
Medical devices-pre-market-authorisation
Medical devices-pre-market-authorisationMedical devices-pre-market-authorisation
Medical devices-pre-market-authorisation
TGA Australia
 
Medical device regulations
Medical device regulationsMedical device regulations
Medical device regulations
garimasaini33
 
TGA webinar presentation: Regulation of software, including software as a med...
TGA webinar presentation: Regulation of software, including software as a med...TGA webinar presentation: Regulation of software, including software as a med...
TGA webinar presentation: Regulation of software, including software as a med...
TGA Australia
 
Sponsor Information and Training day Session B2 - Medical Devices - Accurate ...
Sponsor Information and Training day Session B2 - Medical Devices - Accurate ...Sponsor Information and Training day Session B2 - Medical Devices - Accurate ...
Sponsor Information and Training day Session B2 - Medical Devices - Accurate ...
TGA Australia
 
FDA Guidelines for Medical Devices.pdf
FDA Guidelines for Medical Devices.pdfFDA Guidelines for Medical Devices.pdf
FDA Guidelines for Medical Devices.pdf
Balaji Paulraj
 
Easy medical devices podcast self tests ivdr
Easy medical devices podcast self tests ivdrEasy medical devices podcast self tests ivdr
Easy medical devices podcast self tests ivdr
Erik Vollebregt
 

Similar to TGA Presentation: Medical Devices - Manufacturer Evidence and applications for inclusion in the ARTG (20)

Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...
Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...
Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...
 
Devices Sponsor Information Day - Medical Devices (IVDs) - Applications for A...
Devices Sponsor Information Day - Medical Devices (IVDs) - Applications for A...Devices Sponsor Information Day - Medical Devices (IVDs) - Applications for A...
Devices Sponsor Information Day - Medical Devices (IVDs) - Applications for A...
 
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
 
Devices Sponsor Information Day: Session 3B: Medical devices (IVDs) - applica...
Devices Sponsor Information Day: Session 3B: Medical devices (IVDs) - applica...Devices Sponsor Information Day: Session 3B: Medical devices (IVDs) - applica...
Devices Sponsor Information Day: Session 3B: Medical devices (IVDs) - applica...
 
Devices Sponsor Information Day: 4A - Medical Devices - Audit assessments
Devices Sponsor Information Day: 4A - Medical Devices - Audit assessmentsDevices Sponsor Information Day: 4A - Medical Devices - Audit assessments
Devices Sponsor Information Day: 4A - Medical Devices - Audit assessments
 
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...
 
The challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesThe challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devices
 
Presentation: Update from the Medical Devices Branch
Presentation: Update from the Medical Devices BranchPresentation: Update from the Medical Devices Branch
Presentation: Update from the Medical Devices Branch
 
Sponsor Information and Training day Session C1 - IVDs: eBS applications and ...
Sponsor Information and Training day Session C1 - IVDs: eBS applications and ...Sponsor Information and Training day Session C1 - IVDs: eBS applications and ...
Sponsor Information and Training day Session C1 - IVDs: eBS applications and ...
 
Future of EU In Vitro Diagnostics Regulation
Future of EU In Vitro Diagnostics RegulationFuture of EU In Vitro Diagnostics Regulation
Future of EU In Vitro Diagnostics Regulation
 
EU MDD.pptx
EU MDD.pptxEU MDD.pptx
EU MDD.pptx
 
Devices Sponsor Information Day: 0 - Developments in medical device regulation
Devices Sponsor Information Day: 0 - Developments in medical device regulationDevices Sponsor Information Day: 0 - Developments in medical device regulation
Devices Sponsor Information Day: 0 - Developments in medical device regulation
 
Medical Device Regulatory Approval
Medical Device Regulatory ApprovalMedical Device Regulatory Approval
Medical Device Regulatory Approval
 
Lancashire SME workshop - regulation and medical device workshop
Lancashire SME workshop - regulation and medical device workshopLancashire SME workshop - regulation and medical device workshop
Lancashire SME workshop - regulation and medical device workshop
 
Medical devices-pre-market-authorisation
Medical devices-pre-market-authorisationMedical devices-pre-market-authorisation
Medical devices-pre-market-authorisation
 
Medical device regulations
Medical device regulationsMedical device regulations
Medical device regulations
 
TGA webinar presentation: Regulation of software, including software as a med...
TGA webinar presentation: Regulation of software, including software as a med...TGA webinar presentation: Regulation of software, including software as a med...
TGA webinar presentation: Regulation of software, including software as a med...
 
Sponsor Information and Training day Session B2 - Medical Devices - Accurate ...
Sponsor Information and Training day Session B2 - Medical Devices - Accurate ...Sponsor Information and Training day Session B2 - Medical Devices - Accurate ...
Sponsor Information and Training day Session B2 - Medical Devices - Accurate ...
 
FDA Guidelines for Medical Devices.pdf
FDA Guidelines for Medical Devices.pdfFDA Guidelines for Medical Devices.pdf
FDA Guidelines for Medical Devices.pdf
 
Easy medical devices podcast self tests ivdr
Easy medical devices podcast self tests ivdrEasy medical devices podcast self tests ivdr
Easy medical devices podcast self tests ivdr
 

More from TGA Australia

Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsPharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
TGA Australia
 
Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch
TGA Australia
 
Consumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI templateConsumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI template
TGA Australia
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
TGA Australia
 
Improved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future stateImproved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future state
TGA Australia
 
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...
TGA Australia
 
Updates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesUpdates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changes
TGA Australia
 
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
TGA Australia
 
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
TGA Australia
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
TGA Australia
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
TGA Australia
 
Reporting of Medicine Shortages
Reporting of Medicine ShortagesReporting of Medicine Shortages
Reporting of Medicine Shortages
TGA Australia
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1
TGA Australia
 
Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2
TGA Australia
 
SME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory mazeSME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory maze
TGA Australia
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA Australia
 
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchPresentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access Branch
TGA Australia
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Australia
 
Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...
TGA Australia
 
Presentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & APresentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & A
TGA Australia
 

More from TGA Australia (20)

Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsPharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
 
Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch
 
Consumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI templateConsumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI template
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
 
Improved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future stateImproved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future state
 
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...
 
Updates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesUpdates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changes
 
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
 
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
 
Reporting of Medicine Shortages
Reporting of Medicine ShortagesReporting of Medicine Shortages
Reporting of Medicine Shortages
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1
 
Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2
 
SME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory mazeSME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory maze
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
 
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchPresentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access Branch
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
 
Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...
 
Presentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & APresentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & A
 

Recently uploaded

How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 

Recently uploaded (20)

How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 

TGA Presentation: Medical Devices - Manufacturer Evidence and applications for inclusion in the ARTG

  • 1. Manufacturer Evidence and applications for inclusion in the ARTG Medical Devices Susan Barker Devices Application and Verification Section Medical Devices Branch Devices Sponsor Information Day 11 October 2017
  • 2. Purpose Facilitate better understanding of the regulatory requirements for medical devices ARTG inclusion – explain the process and give some examples 2
  • 3. Overview • Key definitions and regulatory framework • Manufacturer’s Evidence • Information in an application • Avoiding common problems in applications 3
  • 4. What is a medical device? • Used for human beings • Intended purpose – Diagnosis, prevention, monitoring, treatment or alleviation of disease or compensation for injury or disability – Investigation, replacement or modification of anatomy or physiological processes – Control of conception • Principal intended action – Not by pharmacological, immunological or metabolic means • Definition of IVD in the MD Regulations • Products declared to be or not to be a medical device – Therapeutic Goods (Articles that are Medical Devices) Specification and/or Therapeutic Goods (Articles that are not Medical Devices) Orders • Accessory to a medical device as described above Therapeutic Goods Act 1989, section 41BD 4
  • 5. What is an IVD? • A reagent, calibrator, control material, kit, specimen receptacle, instrument, software, equipment or system • Intended for the in vitro examination of human specimens for – giving information about a physiological or pathological state – giving information about a congenital abnormality – determining safety and compatibility with a potential recipient – monitoring therapeutic measures Therapeutic Goods (Medical Devices) Regulations 2002, Dictionary 5
  • 6. ARTG inclusion • Any medical device must be included in ARTG • Except: - Exempt devices (e.g. custom-made medical devices) • Sponsor is responsible for ARTG inclusion • Before you start • TGA Business Services (TBS) – Register and get your Client ID 6
  • 7. Process for ARTG inclusion Basics - process through TGA 7
  • 8. Manufacturer evidence • Manufacturer must apply appropriate conformity assessment procedure to the device (quality management system and control over the design of the device) • Sponsor must lodge the manufacturer’s certification of the conformity assessment with the TGA - Except for Class I medical devices (no measuring function and/or not supplied sterile), Class 1 IVD, and/or Export Only • TGA conformity assessment certificate • EC Certificate issued under MDD 93/42/EEC, AIMDD 90/385/EEC, IVD 98/79/EC • MRA certificates issued by EU Notified Body (with certain exceptions) • Declarations of conformity made under Clause 7.5 of Schedule 3 (systems or procedure packs) • ISO 13485 for IVDs only 8
  • 9. Manufacturer Evidence Submitted Accepted −What does it mean? Go to the next step - lodging application for ARTG inclusion 9
  • 10. Application for ARTG inclusion • Must be made for a kind of device and • Must be made in accordance with a form and manner approved (via TBS) and • Application fee must be paid and • For the devices that must have TGA conformity assessment certificate – such certificate is in force and • Must not contain information that is false or misleading in a material particular Therapeutic Goods Act 1989, sections 41FC and 41EA, and Therapeutic Goods (Medical Devices) Regulations 2002, regulation 4.1 10
  • 11. What we look at Kind of device Intended Purpose GMDN Code Device Product Characteristics Classification Conformity Assessment Procedures 11
  • 12. Kind of device • Sponsor • Manufacturer • Device nomenclature system code (GMDN) • Classification • Unique product identifier (UPI) (for Class III and active implantable medical devices (AIMD), and Class 4IVD, except immunohaematology reagent) a medical device is taken to be of the same kind as another medical device if they have the same: Therapeutic Goods Act 1989, section 41BE and Therapeutic Goods (Medical Devices) Regulations 2002, regulations 1.6 and 1.7 12
  • 13. Intended purpose of a kind of device • Means the purpose for which the manufacturer of the device intends it to be used, as stated in the information provided with the device (labelling, instructions for use, advertising material and technical documentation) • Intended purpose stated in the application must be consistent with the purpose for which the manufacturer intends the devices of the kind to be used Note: The manufacturer must have evidence that the device performs as intended (refer essential principles) 13
  • 14. Global Medical Device Nomenclature (GMDN) - One of the characteristics that defines the kind of device - Is to be consistent with the intended purpose of the device - Must be the code that best describes the kind of device - For medical devices (not-IVD) – relevant preferred term (except Class I – relevant template term) - For IVDs - collective terms (Level 1, 2 or 3) (except Class 4IVD that is not immunohaematology reagent - relevant preferred term) Manufacturer’s responsibility 14
  • 15. Device Product Characteristics • Ensure ‘Device Product Characteristics’ section in the application is correctly filled in 15
  • 16. Medical devices are classified having regard to the intended purpose of the device Class I Class Is and Class Im Class IIa Class IIb Class III and AIMD The lowest level The highest level Therapeutic Goods (Medical Devices) Regulations 2002, Part 3 Division 3.1 and Schedules 2 16
  • 17. IVD medical devices are classified having regard to the intended purpose of the device and its risk to public health and/or personal risk • Class 1 IVD – no public health risk or low personal risk • Class 2 IVD – low public health risk or moderate personal risk • Class 3 IVD – moderate public health risk or high personal risk • Class 4 IVD – high public health risk RISK Therapeutic Goods (Medical Devices) Regulations 2002, Schedules 2A 17
  • 18. Conformity assessment procedure • Minimum conformity assessment procedures for different Classes of devices • Sufficient information to demonstrate application of the appropriate conformity assessment procedures to the kind of device Part 3 Division 3.2 and Schedule 3, Therapeutic Goods (Medical Devices) Regulations 2002 18
  • 19. Conformity assessment procedures • Minimum conformity assessment procedures for different Classes of devices Class Is device (e.g. Sterile surgical gown) Class III device supplied sterile (e.g. Knee Femur) Annex II.3 - Full Quality Assurance Annex V – Production Quality Plus Declaration of conformity (Part 6, Schedule 3) Annex III - Type Examination Plus: Annex V - Production Quality Assurance Annex II.3 - Full Quality Assurance Plus Annex II.4 - Examination of Design OR OR 19
  • 20. One page document • Describe the device and intended purpose if needed in more detail • Cite the classification rules in accordance with Schedule 2 or 2A of the Regulations and provide justification where required • Explain how the kind of device is covered under the scope of certificate included in Manufacturer’s Evidence • Make sure all the information is complete and correct • Do not attach more than one page 20
  • 21. Information provided in the application • Do not attach information that is not relevant with the application, for example: – Declaration of conformity made under EU Medical Device Directive – Audit and/or technical data reports • Ensure intended purpose is clear and correct • Ensure the device is classified correctly • Ensure the Manufacturer’s Evidence stated in the application contains correct certificate 21
  • 22. Examples of common mistakes Incorrect Device Product Characteristics GMDN code not most relevant for the kind of device Incorrect Classification Scope of EC certificate does not correctly cover the kind of device Attaching documents not relevant, which do not meet requirements 22
  • 23. Where do we go from here? Matters certified under s.41FD Ensure all information provided is correct Any application may be selected for audit Some applications must be selected for audit 23
  • 24. SME Assist • Guidance on TGA website • Interactive online tool 24
  • 25. Further information • Medical devices (http://www.tga.gov.au/medical-devices-ivds) • SME Assist (https://www.tga.gov.au/sme-assist) TGA website • Therapeutic Goods Act 1989 Chapter 3, Part 4-5 • Therapeutic Goods (Medical Devices) Regulations 2002 Federal Register of Legislation • devices@tga.gov.au ph.: 1800 141 144 Contact the TGA Medical Devices Branch 25
  • 27.
  • 28. Juliana William Sr RA Associate Baxter Healthcare 11/10/2017 Devices Sponsor Information Day 28
  • 29. Agenda Successful and Efficient Submission  Preparation  Checks to do  Additional information  Non-mandatory audit submissions This presentation will not cover details of: • Systems and Procedure Packs • Conformity Assessment • Audit Assessment • Class III/AIMD, UPI and Variants • Clinical Evidence & Risk Assessment compliance 11/10/2017 Devices Sponsor Information Day 29
  • 30. Common Deficiencies Manufacturer Evidence (ME) • Two or more certificates are provided • EU declaration of Conformity • ISO 13485 certificate • Incomplete certificate (missing attachments) • Incorrect annex route • Incorrect directive • Not in English! Device Application (DA) • GMDN code does no match the ‘Intended purpose’ • Wrong classification • Device is not covered in the EC Certificate scope • Route of conformity (EC Certificate Annex) is not appropriate for the proposed Class • Wrong manufacturer evidence! Administrative • Missing documents or pages! • TGA evaluator unable to find information easily • Poor hyperlinking and bookmarking • Spelling errors • Poor English Translation • Missing signatures! • Application fees not processed 11/10/2017 Devices Sponsor Information Day 30
  • 31. Preparation  Ensure a legal/quality/distribution agreement is/are in place which outline clearly roles and responsibilities for post-market monitoring, vigilance and reporting obligations  Obtain Australian Declaration of Conformity from manufacturer  Make sure you have the right template for class and conformity route. See http://www.tga.gov.au/industry/devices-forms-declaration-conformity.htm  Ensure the codes listed are the code to be registered and marketed  Obtain Australian Essential Principles Checklist from manufacturer ● Ensure compliance with all standards applied and compliance with the Australian EP. Section 8 of the ARGMD explain the differences between EU ER and Australia EP.  Product Labelling and Instruction for Use  Risk Management Report and Clinical Evaluation Report 11/10/2017 Devices Sponsor Information Day 31
  • 32. Checks to Do  Check whether the device:  Sterile? What is the sterilisation method  Measuring function?  Invasive?  Reusable or Single Use?  Active?  Single product or System or Procedure pack?  Contains a medicine?  Contains material or ingredients of microbial/ recombinant / GMO/ animal/ human origin? Country of origin?  Is the device classified correctly according to the TGA Classification Rules? (Schedule 2 of The Regulations) 11/10/2017 Devices Sponsor Information Day 32
  • 33. Checks to Do The medical devices regulatory framework has a classification system for medical devices. The detailed legislation is in: • 41BD of the Therapeutic Goods Act 1989 (the Act) • Regulation 3.2 of the Therapeutic Goods (Medical Devices) Regulations 2002 (the Regulations) • Schedule 2 of the Regulations. 11/10/2017 Devices Sponsor Information Day 33
  • 34. Checks to Do • Is the assigned GMDN code appropriate? (Section 10 of the Regulation)  Remember that manufacturer assign the GMDN code.  Check if the GMDN is on the TGA database. If the GMDN code is not in the TGA database, ask for it to be added in advance by email to ebs@tga.gov.au  There may be differences between the GMDN Agency code table database and the TGA code table database.  Based on the Device information, is the GMDN appropriate and reflects the intended purpose?  Must be a preferred term  Does the device perform according to its intended purpose?  This should be a detailed description of the manufacturers intended purpose and should closely align with the relevant GMDN description  Remember: Intended purpose is different from Functional description (describes the operation of the medical device, not its composition) 11/10/2017 Devices Sponsor Information Day 34
  • 35. Checks to Do ● Is the device same kind of medical device (Section 41BE of The Act)? A medical device is of the same ‘kind’ if it has the same:  Intended purpose  Classification  GMDN code  Legal manufacturer  Sponsor  Does it have appropriate evidence of Conformity Assessment?  ARGMD Section 5 Conformity Assessment Overview  Need to check the appropriate level and route is held by the manufacturer according to the classification 11/10/2017 Devices Sponsor Information Day 35
  • 36. Checks to Do 11/10/2017 Devices Sponsor Information Day 36
  • 37. Checks to Do There are a number of important details that a sponsor should check to ensure that the certificate is valid for particular devices. Refer to Section 7 of the ARGMD 11/10/2017 Devices Sponsor Information Day 37
  • 38. Additional Information If there is additional information that could help the assessor, then it would be beneficial to attach a ONE PAGE ONLY document with the application illustrating:  A Picture/diagram of the device  A description of the device (not the intended purpose)  A description of the mechanism of action (how it works)  How the device is included in the scope of the CE Certificate  Evidence of the same kind of medical device (for multiple devices) 11/10/2017 Devices Sponsor Information Day 38
  • 39. Non-mandatory audit  Any Device Application is subject to non-mandatory audit.  Be prepared to submit any documents from Level 1 or 2 audit list, as well as anything else you may need to show compliance with any of the Essential Principles or Conformity Assessment Procedures. Examples:  Compliance with Essential Principles  Notified Body audit reports to verify the validity of the EC Certificate  Product labelling and IFU  Explanation and justification of Classification  Recent Clinical Evaluation Report  Recent Risk Management File  Compliance with particular standards (or justification why it is not complied with)  Remember you declare you can submit in 20 days! 11/10/2017 Devices Sponsor Information Day 39
  • 40. Non-mandatory audit  Provides all items requested by the TGA  Electronic and easy to navigate (entire document):  Clear table of content (hyperlinking and bookmarking work!)  Text readable  Page numbers throughout  Up-to-date Clinical Evidence Report (signed by a clinical expert!)  Up-to-date Risk Management File  Well prepared submission will:  Allow the delegate to easily navigate and find information quickly.  Reduce the number of questions raised by the delegate  Speed approval The better quality the submission, the easier it is to read and evaluate 11/10/2017 Devices Sponsor Information Day 40
  • 41. Wrap Up  Make sure you understand your product.  Do your preparation and verify information before submission! Time spent before submitting is well worth it and will increase your success rate  Engage your cross function team (R&D/Quality/Medical/Clinical..etc) well in advance of your submission plan. Discuss application requirements and TGA’s expectation.  Submit meaningful, helpful and well-set out information. Perform second check before sending application and electronic files  Clearly explain the scope of your application in the cover letter  Provide comprehensive Table of Content  Ensure all hyperlinks and bookmarks are actually working  Ensure all documents and attachments are provided with the application!  Don’t submit extra documents that aren’t useful or haven’t been requested 11/10/2017 Devices Sponsor Information Day 41
  • 42. References The Act Therapeutic Goods Act 1989 The Regulations Therapeutic Goods (Medical Device) Regulations 2002 ARGMD Australian Regulatory Guidance for Medical Devices 11/10/2017 Devices Sponsor Information Day 42